viking therapeutics is a company that is working on making special medicines to help people who are overweight or have a sickness in their liver. their medicines are still being tested, but they are showing promise, which means they might be able to help people in the future. because of this, the company's stock price has gone up a lot recently. stock price is like a score that shows how much people believe in a company and its ideas. Read from source...

no
### Sell:
Sell's article story critics, highlighted inconsistencies, biases, irrational arguments, emotional behavior: no
### HOLD:
HOLD's article story critics, highlighted inconsistencies, biases, irrational arguments, emotional behavior: no
### Buy:
Buy's article story critics, highlighted inconsistencies, biases, irrational arguments, emotional behavior: no
### Portfolio:
Portfolio's article story critics, highlighted inconsistencies, biases, irrational arguments, emotional behavior: no

bullish

Reasoning: The article has a bullish sentiment on Viking Therapeutics' (VKTX) pipeline candidates, with the company's shares soaring nearly 25% in the past month, all thanks to progress with its investigational obesity and non-alcoholic steatohepatitis (NASH) candidates. Management plans to advance these candidates to late-stage development by early 2025. The company's pipeline advancements, along with promising results from clinical studies, could trigger share price movements and make VKTX an attractive acquisition target by big pharma.

for a more informed decision, don't hesitate to consult a certified financial advisor. This article is for informational purposes only, and it's not financial advice. Past performance is not a guarantee of future results.